COVID-19 vaccine candidate begins late-stage U.S. study

ad+1

AstraZeneca will give 30,000 people either the experimental vaccine, dubbed AZD1222, or a placebo


from World - The Globe and Mail
Read The Rest:theglobeandmail...

0 comments: